|
PLEKHA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.801400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.818800E-01 |
| Normal-vs-Stage2 |
1.035840E-01 |
| Normal-vs-Stage3 |
8.596400E-01 |
| Normal-vs-Stage4 |
6.204400E-01 |
| Stage1-vs-Stage2 |
7.664100E-02 |
| Stage1-vs-Stage3 |
8.052800E-01 |
| Stage1-vs-Stage4 |
5.750200E-01 |
| Stage2-vs-Stage3 |
1.197350E-01 |
| Stage2-vs-Stage4 |
7.685700E-02 |
| Stage3-vs-Stage4 |
4.840000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.128400E-01 |
| Normal-vs-AfricanAmerican |
3.697200E-01 |
| Normal-vs-Asian |
2.915800E-01 |
| Caucasian-vs-AfricanAmerican |
2.865200E-01 |
| Caucasian-vs-Asian |
1.632010E-01 |
| AfricanAmerican-vs-Asian |
8.540000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.059000E-01 |
| Normal-vs-Female |
9.334000E-01 |
| Male-vs-Female |
3.439200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.809200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.689000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.778000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.084800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.933600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.596400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.748600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.895200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.393400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.477200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.782600E-01 |
| Classical-VS-Follicular |
4.056100E-03 |
| Classical-VS-Other |
4.367200E-01 |
| Classical-VS-Normal |
4.980800E-01 |
| Tall-VS-Follicular |
8.615800E-02 |
| Tall-VS-Other |
3.879600E-01 |
| Tall-VS-Normal |
5.009600E-01 |
| Follicular-VS-Other |
8.546000E-01 |
| Follicular-VS-Normal |
1.216430E-01 |
| Other-VS-Normal |
5.745200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.700160E-01 |
| Normal-vs-N1 |
8.140600E-01 |
| N0-vs-N1 |
4.259200E-01 |
|
|
